Lepu Medical > News > Exhibition > Invitation to EuroPCR 2017 !
Invitation to EuroPCR 2017 !
Lepu Medical will participate in EuroPCR held in Palais des Congrès, Paris, France, during May 16-19, 2017. The booth No. is M42.
At EuroPCR 2017, Lepu Medical is going to display series of interventional products concentrating in cardiac therapy. Welcome to visit us at booth M42 to get to know more about Lepu products! Lepu Medical do hope that we could have the opportunity to work with you!

Look forward to meet you in Paris!

About EuroPCR

EuroPCR is the official annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the world-leading Course in interventional medicine.

EuroPCR is the flagship of all PCR educational events by size, but also by offering: it is the global forum for sharing within and between all interventional communities. The diversity of PCR communities is apparent in the various common denominators around which they form. Whether it is by interest, activity or generation, by disease track (from coronary intervention to heart failure), by nationality, by primary interest (CTO, invasive physiology, mitral repair, clinical research, bifurcation PCI, innovation), by practice: colleagues find each other here in Paris.

EuroPCR promises to keep pushing boundaries in education, setting the stage to present latest technologies, services and innovations to an eager 12,000+ members of the worldwide interventional cardiovascular community.

About Lepu Medical
Lepu Medical Technology (Beijing) Co., Ltd. was established in 1999. Lepu Medical is specialized in developing, manufacturing and distributing the high-tech medical devices and equipment. Today, Lepu Medical has grown into a global leading group company in the fields of cardiovascular, neurovascular and peripheral vascular interventions, structural heart diseases, surgical cardiology, cardiac rhythm management, anesthesia and intensive care, in vitro diagnostics and general surgery. In 2009, Lepu Medical successfully listed on ChiNext Shenzhen Stock Exchange market (stock code: 300003).

Now Lepu Medical totally has 28 primary subsidiary companies worldwide. There are more than 60 products have received the CE certificates, and 6 products have got the FDA approvals. Lepu Medical has established three overseas subsidiary companies in Netherland, Turkey and India, obtained local registrations in 27 countries, and built the sales and distribution channels in over 80 countries and regions.

Lepu Medical upholds “integrity, quality and scientific innovation” as its spirit, commitments to provide the best quality of products and services to satisfy the needs of healthcare professionals and patients.


SOURCE: Lepu Medical International Sales & Marketing Department



© Copyright  1999-2014  lepumedical.com,  All rights reserved
版权所有    乐普(北京)医疗器械股份有限公司    京ICP备13012321号